— Know what they know.
Not Investment Advice

REKA.TA TLV

Rekah Pharmaceutical Industry Ltd.
1W: -0.1% 1M: +12.5% 3M: +11.9% YTD: -1.1% 1Y: -2.2% 3Y: -29.5% 5Y: -50.0%
₪1,145.00 ($3.75)
-31.00 (-2.64%)
 
TLV · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 70 · ₪130.7M mcap · 2M float · 0.179% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₪130.7M ($0.4M)
52W Range1006-1348
Volume1,509
Avg Volume3,365
Beta0.11
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMordechai Elgrabli
Employees390
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2002-08-12
30 Hamelach Street
Holon, TA 5881904
IL
972 3 558 1233
About Rekah Pharmaceutical Industry Ltd.

Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in Holon, Israel, specializes in the production, marketing, distribution, and sale of a broad spectrum of healthcare items across Israel. The company's offerings include both prescription and over-the-counter medicines, dermo-cosmetic products, vitamins, and nutritional supplements. Its extensive portfolio comprises approximately 280 distinct pharmaceutical drugs used in various medical sectors. These encompass steroid tablets, antibiotics (such as penicillin and cephalosporin), eye drops and ointments for allergies, infections, and dryness, baby products, and dermatological treatments.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms